Cancer
therapeutic strategies based on angiogenesis attract great
attention from fundamental and clinical research. Blocking oxygen
and nutrition supply to tumor cells could inhibit the growth of tumors
based on occlusion of blood vessels in the tumor. Herein, we report
a dual-responsive peptide-based nanoparticle, mimicking the laminin
fibrillogenesis specifically and highly efficiently in tumor vessels,
resulting in the blockage of tumor vessels and the growth inhibition
of tumors. The laminin mimic peptide (LMMP) is designed with a fibrillation
sequence, a pH-responsive sequence, and a targeting sequence. The
LMMP in nanoformulations is delivered to blood vessels in the tumors,
where the microenvironment (pH and microthrombus) enable LMMP to process
laminin fibrillogenesis, constructing fibrous networks. The laminin-like
fibrous networks capture red blood cells etc., forming
occlusion specifically in the tumor blood vessels to inhibit the growth
of the tumor.